<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Amino Acids</journal-id><journal-id journal-id-type="iso-abbrev">Amino Acids</journal-id><journal-title-group><journal-title>Amino Acids</journal-title></journal-title-group><issn pub-type="ppub">0939-4451</issn><issn pub-type="epub">1438-2199</issn><publisher><publisher-name>Springer Vienna</publisher-name><publisher-loc>Vienna</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27193231</article-id><article-id pub-id-type="pmc">4974290</article-id><article-id pub-id-type="publisher-id">2252</article-id><article-id pub-id-type="doi">10.1007/s00726-016-2252-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Creatine ingestion augments dietary carbohydrate mediated muscle glycogen supercompensation during the initial 24&#x000a0;h of recovery following prolonged exhaustive exercise in humans</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>Paul A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fox</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Peirce</surname><given-names>Nicholas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Simon W.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Casey</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Greenhaff</surname><given-names>Paul L.</given-names></name><address><phone>+44 (0)115 8230133</phone><email>paul.greenhaff@nottingham.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>School of Biomedical Sciences, Queen&#x02019;s Medical Centre, University of Nottingham, Nottingham, NG7 2UH UK </aff><aff id="Aff2"><label>2</label>Human Metabolic Physiology and Nutrition, QinetiQ Centre for Human Sciences, Farnborough, UK </aff><aff id="Aff3"><label>3</label>School of Life Sciences, The Medical School, Nottingham, NG7 2UH UK </aff></contrib-group><author-notes><fn fn-type="com"><p>Handling editor: T. Wallimann and R. Harris.</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>48</volume><fpage>1831</fpage><lpage>1842</lpage><history><date date-type="received"><day>21</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>3</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p>Muscle glycogen availability can limit endurance exercise performance. We previously demonstrated 5&#x000a0;days of creatine (Cr) and carbohydrate (CHO) ingestion augmented post-exercise muscle glycogen storage compared to CHO feeding alone in healthy volunteers. Here, we aimed to characterise the time-course of this Cr-induced response under more stringent and controlled experimental conditions and identify potential mechanisms underpinning this phenomenon. Fourteen healthy, male volunteers cycled to exhaustion at 70&#x000a0;% <italic>V</italic>O<sub>2peak</sub>. Muscle biopsies were obtained at rest immediately post-exercise and after 1, 3 and 6&#x000a0;days of recovery, during which Cr or placebo supplements (20&#x000a0;g&#x000a0;day<sup>&#x02212;1</sup>) were ingested along with a prescribed high CHO diet (37.5&#x000a0;kcal&#x000a0;kg body mass<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>, &#x0003e;80&#x000a0;% calories CHO). Oral-glucose tolerance tests (oral-GTT) were performed pre-exercise and after 1, 3 and 6&#x000a0;days of Cr and placebo supplementation. Exercise depleted muscle glycogen content to the same extent in both treatment groups. Creatine supplementation increased muscle total-Cr, free-Cr and phosphocreatine (PCr) content above placebo following 1, 3 and 6&#x000a0;days of supplementation (all <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). Creatine supplementation also increased muscle glycogen content noticeably above placebo after 1&#x000a0;day of supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), which was sustained thereafter. This study confirmed dietary Cr augments post-exercise muscle glycogen super-compensation, and demonstrates this occurred during the initial 24&#x000a0;h of post-exercise recovery (when muscle total-Cr had increased by &#x0003c;10&#x000a0;%). This marked response ensued without apparent treatment differences in muscle insulin sensitivity (oral-GTT, muscle GLUT4 mRNA), osmotic stress (muscle <italic>c</italic>-<italic>fos</italic> and HSP72 mRNA) or muscle cell volume (muscle water content) responses, such that another mechanism must be causative.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Glycogen storage</kwd><kwd>Glucose tolerance</kwd><kwd>Phosphocreatine</kwd><kwd>Insulin sensitivity</kwd></kwd-group><funding-group><award-group><funding-source><institution>Chemical Biological Defence and Human Sciences Domain of the UK MoD Corporate Research Programme</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Wien 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Muscle glycogen availability has long been cited as a principal determinant of endurance exercise performance, and its depletion corresponds with the development of muscle fatigue (Bergstr&#x000f6;m and Hultman <xref ref-type="bibr" rid="CR5">1967</xref>; Bergstr&#x000f6;m et al. <xref ref-type="bibr" rid="CR6">1967</xref>). Optimising liver and muscle glycogen storage is a goal of many athletes wishing to maximise performance, particularly those involved in disciplines requiring prolonged sub-maximal exertion (65&#x02013;75&#x000a0;% <italic>V</italic>O<sub>2peak</sub>) or repeated bursts of high intensity exercise. The accepted method of maximising muscle glycogen content is by &#x02018;carbohydrate (CHO) loading&#x02019;, which classically involves the depletion of muscle glycogen reserves through prolonged sub-maximal exercise (&#x0003e;90&#x000a0;min), followed by the consumption of a high CHO diet (&#x0003e;70&#x000a0;% calories CHO) for several days (Bergstr&#x000f6;m and Hultman <xref ref-type="bibr" rid="CR4">1966</xref>, <xref ref-type="bibr" rid="CR5">1967</xref>; Sherman and Costill <xref ref-type="bibr" rid="CR48">1984</xref>). The use of such methods has been shown to replenish muscle glycogen content to a habitual resting level within 24&#x000a0;h, and to super-compensate reserves by over 100&#x000a0;% within 48&#x02013;72&#x000a0;h. As a result of this, improvements in subsequent endurance exercise performance (time to fatigue<italic>)</italic> of about 50&#x000a0;% can be expected (Bergstr&#x000f6;m and Hultman <xref ref-type="bibr" rid="CR5">1967</xref>). This super-compensatory response is confined solely to the previously exercised (glycogen-depleted) muscle, and has been attributed to heightened muscle insulin sensitivity and a localised increase in glycogen synthase activity (Bergstr&#x000f6;m and Hultman <xref ref-type="bibr" rid="CR5">1967</xref>, <xref ref-type="bibr" rid="CR4">1966</xref>; Jentjens and Jeukendrup <xref ref-type="bibr" rid="CR34">2003</xref>).</p><p>We have previously demonstrated that dietary Cr supplementation can augment post-exercise muscle glycogen storage during a conventional &#x02018;CHO-loading&#x02019; regimen in healthy, young, male volunteers, and that this response is restricted to the previously exercised limb (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>; Sewell et al. <xref ref-type="bibr" rid="CR47">2008</xref>). Furthermore, in keeping with the data of Harris et al. (<xref ref-type="bibr" rid="CR31">1992</xref>), we confirmed that exercise can augment muscle Cr storage (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>). Of practical importance, this Cr-mediated augmentation of post-exercise muscle glycogen storage was of a magnitude sufficient to produce a significant improvement in endurance exercise performance (~150&#x000a0;mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle; Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>). Although Cr ingestion is well established as a method to improve performance during, and recovery from (in the form of PCr re-synthesis), short-term maximal exercise (Greenhaff et al. <xref ref-type="bibr" rid="CR26">1993</xref>, <xref ref-type="bibr" rid="CR27">1994</xref>), the work of Robinson et al. (<xref ref-type="bibr" rid="CR44">1999</xref>) highlighted for the first time the potential beneficial effect of Cr supplementation on the performance of, and maximising recovery from, prolonged sub-maximal exercise. The findings of Robinson et al. (<xref ref-type="bibr" rid="CR44">1999</xref>) have since been supported by rodent (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR15">2001a</xref>) and human (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>; Derave et al. <xref ref-type="bibr" rid="CR13">2003</xref>; Van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>) based investigation. The time-course of this Cr-mediated effect on glycogen storage remains unknown, but based on the findings of Robinson et al. (<xref ref-type="bibr" rid="CR44">1999</xref>) must occur somewhere between 6 and 120&#x000a0;h of post-exercise Cr ingestion. Similarly, insight is lacking into the mechanisms that underpin this phenomenon.</p><p>There are a number of potential mechanisms that might underpin the ability of dietary Cr supplementation to augment post-exercise muscle glycogen storage. First, a Cr-induced increase in post-exercise insulin release and/or increase in muscle insulin sensitivity. This hypothesis could be tested by performing an oral-glucose tolerance test (oral-GTT) before exercise and at several pre-determined time points during recovery from exercise, during which volunteers ingest Cr and CHO or CHO alone, and blood glucose and serum insulin are determined. Furthermore, depending upon the time-course of the glycogen super-compensatory response, a Cr-induced augmentation in muscle sarcolemmal glucose transporter (GLUT4) might occur in tandem with these responses (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>). Second, an increase in post-exercise glycogen storage could be directly linked to a Cr-induced increase in muscle water content. Indeed, osmotically induced swelling of rat muscle fibres in vitro has demonstrated that muscle glycogen synthesis can be increased by changes in cell volume (Low et al. <xref ref-type="bibr" rid="CR38">1996</xref>). Taken in tandem with the decreases in urinary volume and increases in fat-free body mass often reported following Cr ingestion (Hultman et al. <xref ref-type="bibr" rid="CR33">1996</xref>; Dentowski et al. <xref ref-type="bibr" rid="CR12">1997</xref>), if muscle Cr accumulation (which is sodium dependent) does result in cell swelling in vivo in humans (Francaux and Poortmans <xref ref-type="bibr" rid="CR20">1999</xref>), then this may indeed underpin an increase in post-exercise glycogen storage. This could be tested by determining Cr-mediated alterations in muscle water content in tandem with changes in the expression of transcription factors known to be sensitive to osmotic stress responses in humans, for example, <italic>c</italic>-<italic>fos</italic> and the inducible 70&#x000a0;kDa heat shock protein (HSP72; Locke <xref ref-type="bibr" rid="CR37">1997</xref>; Sadoshima and Izumo <xref ref-type="bibr" rid="CR46">1997</xref>; Beck et al. <xref ref-type="bibr" rid="CR2">2000</xref>). Finally, given exercise-induced muscle glycogen depletion is known to accompany increased muscle 5&#x02032;AMP activated protein kinase (AMPK) activation, which in turn has been linked to the mechanistic regulation of post-exercise muscle glucose disposal and storage (Wojtaszewski et al. <xref ref-type="bibr" rid="CR56">2003</xref>; Steinberg et al. <xref ref-type="bibr" rid="CR49">2006</xref>), it is plausible that a Cr-mediated alteration in exercise-induced AMPK activation could modulate post-exercise muscle glycogen storage. Whilst AMPK is principally activated through changes in the AMP/ATP ratio (Hardie <xref ref-type="bibr" rid="CR29">2004</xref>; Hardie and Hawley <xref ref-type="bibr" rid="CR28">2001</xref>), a change in the PCr/Cr ratio, which is known to accompany Cr feeding in human muscle (Harris et al. <xref ref-type="bibr" rid="CR31">1992</xref>; Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>), is also known to modulate AMPK activity (Ponticos et al. <xref ref-type="bibr" rid="CR41">1998</xref>). Furthermore, AMPK has been reported to be activated indirectly by changes in cell osmotic stress (Hayashi et al. <xref ref-type="bibr" rid="CR32">2000</xref>; Fryer et al. <xref ref-type="bibr" rid="CR21">2002</xref>).</p><p>The primary aim of the present study, therefore, was to extend the findings of Robinson et al. (<xref ref-type="bibr" rid="CR44">1999</xref>) and to delineate the time-course of Cr-mediated post-exercise muscle glycogen super-compensation in humans, but under more stringent and controlled experimental conditions. We also hoped to provide some insight into potential mechanisms that could underpin this Cr-mediated phenomenon.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Subjects</title><p>Fourteen recreationally active (non-highly trained) and non-vegetarian healthy men (age 26&#x000a0;&#x000b1;&#x000a0;2&#x000a0;years; height 180&#x000a0;&#x000b1;&#x000a0;1&#x000a0;cm; body mass 78.6&#x000a0;&#x000b1;&#x000a0;3.9&#x000a0;kg; body mass index 24.5&#x000a0;&#x000b1;&#x000a0;1.0&#x000a0;kg&#x000a0;m<sup>&#x02212;2</sup>; <italic>V</italic>O<sub>2peak</sub> 44.4&#x000a0;&#x000b1;&#x000a0;1.5&#x000a0;ml&#x000a0;kg<sup>&#x02212;1</sup> body mass&#x000a0;min<sup>&#x02212;1</sup>), with no history of prior Cr supplementation, volunteered to participate in the present study. The study was approved by the University of Nottingham Medical School Ethics Committee and conformed to the Declaration of Helsinki. Subjects were advised of the rationale, associated risks and procedures of the study and were aware that they were free to withdraw from the study at any time. Before commencing the investigation, all subjects gave informed written consent, and routine blood and physiological measurements were performed to assess health status prior to acceptance into the study.</p></sec><sec id="Sec4"><title>Maximal oxygen uptake determination</title><p>Upon satisfying the screening criteria, each subject visited the laboratory on two occasions during which they were familiarised with the experimental procedures to be used throughout the study and their peak oxygen uptake (<italic>V</italic>O<sub>2peak</sub>) was measured and confirmed. The determination of <italic>V</italic>O<sub>2peak</sub> involved the use of an online gas analysis system (SensorMedics, Anaheim, CA, USA) and a continuous incremental exercise protocol on an electrically braked bicycle ergometer at a pedalling cadence of ~70&#x000a0;rpm (Excaliber Sport, Lode N.V. Instrumenten, Groningen, The Netherlands).</p></sec><sec id="Sec5"><title>Experimental protocol (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>)</title><p>Subjects reported to the laboratory on the morning of the study after an overnight fast, having abstained from alcohol and strenuous exercise for a minimum of 48&#x000a0;h. Upon arrival, subjects were weighed and then rested in a supine position with their non-dominant hand placed in a hand-warming unit (in which air temperature was maintained at 55&#x000a0;&#x000b0;C) to arterialise the venous drainage of the hand (Gallen and Macdonald <xref ref-type="bibr" rid="CR23">1990</xref>). After 20&#x000a0;min, a cannula was inserted into an antecubital vein on the dorsal surface of the subject&#x02019;s hand, and the hand was returned to the hand-warming unit. The cannula was kept patent using an isotonic saline drip. Subjects then underwent a 2-h oral-glucose tolerance test (GTT), where 90&#x000a0;g of simple CHO was ingested in a 500&#x000a0;ml solution (&#x0003c;2&#x000a0;min), with arterialised-venous blood samples being taken immediately prior to CHO ingestion and 15, 30, 45, 60, 80, 100 and 120&#x000a0;min post-ingestion for the subsequent analysis of the whole blood glucose and lactate (YSI 2300 Statplus analyser, YSI, Yellow Springs, OH, USA), non-esterified free fatty acid (NEFA C kit, Wako Chemicals, Wako, Germany) and serum insulin (Diagnostic Products, Los Angeles, CA, USA) concentrations. Throughout the oral-GTT subjects continued to rest in a supine position and their hand remained in the hand-warming unit to ensure venous arterialisation was maintained.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Diagrammatic overview of the experimental protocol</p></caption><graphic xlink:href="726_2016_2252_Fig1_HTML" id="MO1"/></fig></p><p>Upon completion of the oral-GTT, the cannula was removed and subjects immediately began exercising on an electrically braked bicycle ergometer (Excaliber Sport, Lode N.V. Instrumenten, Groningen, The Netherlands) at 70&#x000a0;% <italic>V</italic>O<sub>2peak</sub> and a pedal cadence of 70&#x000a0;rpm. Expired gas composition and volume was measured throughout the first 15&#x000a0;min of exercise to confirm subjects were exercising at the correct workload. Perceived exertion was assessed every 15&#x000a0;min during exercise using the Borg scale (Borg <xref ref-type="bibr" rid="CR7">1982</xref>). To prevent excessive dehydration during exercise, subjects received 2&#x000a0;ml of water&#x000a0;kg<sup>&#x02212;1</sup> body mass every 20&#x000a0;min throughout the exercise period. Subjects exercised continuously until they could no longer maintain a cycling cadence of 70&#x000a0;rpm and wished to stop. At this point, they were allowed to rest supine on a bed for 5&#x000a0;min, and then continued to exercise, interleaved with short rest periods, until the required cycling cadence could no longer be maintained for 2&#x000a0;min or the subject chose not to continue (point of exhaustion). This glycogen-depleting protocol has been used previously by this research laboratory to achieve almost complete muscle glycogen depletion (Casey et al. <xref ref-type="bibr" rid="CR8">1996</xref>).</p></sec><sec id="Sec6"><title>Muscle biopsy sampling and treatment groups (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>)</title><p>At the point of exhaustion, subjects stepped away from the exercise apparatus and rested supine on a bed, whilst a muscle biopsy was immediately obtained from the vastus lateralis of the non-dominant leg using the Bergstr&#x000f6;m needle biopsy technique (Bergstr&#x000f6;m <xref ref-type="bibr" rid="CR3">1975</xref>). Upon removal from the limb, the muscle biopsy sample was snap frozen in liquid nitrogen and stored under liquid nitrogen for analysis at a later date. Subjects were then randomly assigned to either a Cr monohydrate (20&#x000a0;g&#x000a0;day<sup>&#x02212;1</sup>) or placebo (glycine 20&#x000a0;g&#x000a0;day<sup>&#x02212;1</sup>) treatment group for the remainder of the day and subsequent 5&#x000a0;days. A further muscle biopsy, followed immediately by an oral-GTT, was performed after 1, 3 and 6&#x000a0;days of Cr and placebo ingestion. To avoid potential confounding metabolic effects arising from multiple biopsy sampling over the course of the study, biopsy sites were separated by at least 2.5&#x000a0;cm (Murton et al. <xref ref-type="bibr" rid="CR39">2014</xref>).</p><p>The Cr treatment group (<italic>n</italic>&#x000a0;=&#x000a0;7) ingested 5&#x000a0;g of Cr (Cr monohydrate; AlzChem, Trostberg, Germany) on four equally spaced occasions each day over a 6&#x000a0;day period, whilst the placebo group (<italic>n</italic>&#x000a0;=&#x000a0;7) received 5&#x000a0;g of glycine (Ajinomoto Inc., Tokyo, Japan) at the same time points. Each 5&#x000a0;g supplement (dissolved in 250&#x000a0;ml of a warm, sugar-free, diluted orange drink) was consumed, and immediately followed by the ingestion of 500&#x000a0;ml of a commercially available CHO-rich drink (Lucozade Original &#x02248;18.5&#x000a0;% w/v glucose and simple sugars, Smith-Kline Beecham, Coleford, UK). This supplementation protocol ensures each Cr supplement is fully dissolved, and the peak in plasma Cr concentration coincides with peak elevations in blood glucose and serum insulin concentration (Green et al. <xref ref-type="bibr" rid="CR24">1996a</xref>, <xref ref-type="bibr" rid="CR25">b</xref>). The CHO dose was chosen because it is known to stimulate muscle Cr and glycogen accumulation in young, healthy volunteers (Green et al. <xref ref-type="bibr" rid="CR24">1996a</xref>, <xref ref-type="bibr" rid="CR25">b</xref>; Robinson et al. <xref ref-type="bibr" rid="CR45">2000</xref>). Supplement ingestion commenced immediately after the post-exercise muscle sample (1st biopsy). Before leaving the laboratory, subjects consumed a second treatment (supplement), as detailed previously, and a further two supplements were ingested at intervals over the remainder of that day. Typically, the supplements were ingested at ~12, 2, 6 and 10&#x000a0;pm daily. Subjects repeated the ingestion of the supplements four times each day for a further 5&#x000a0;days. In addition to the supplements, subjects consumed a commercially prepared CHO-rich diet (&#x02018;Be Good To Yourself&#x02122;&#x02019; food range, Sainsburys, UK), which when added to the 2&#x000a0;l of Lucozade consumed each day, equated to greater than 80&#x000a0;% of the calorific intake being in the form of CHO throughout the 6&#x000a0;day treatment period (~8&#x000a0;g CHO kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>). As subjects received 1350&#x000a0;kcal per day from the Lucozade drinks alone, to ensure that protein intake was not reduced from recommended levels, subjects received 20&#x000a0;% more calories per day than required based on their body mass (37.5&#x000a0;kcal&#x000a0;kg<sup>&#x02212;1</sup> body mass&#x000a0;day<sup>&#x02212;1</sup>). This regimen of Cr ingestion has been widely used and has been proven to have no adverse side effects (Robinson et al. <xref ref-type="bibr" rid="CR45">2000</xref>), to increase plasma Cr concentration to a peak of ~700&#x000a0;&#x000b5;mol&#x000a0;l<sup>&#x02212;1</sup> when co-ingested with CHO (Green et al. <xref ref-type="bibr" rid="CR24">1996a</xref>) and to markedly increase muscle total-Cr content.</p><p>Twenty-four h urine collections were made over the first day of supplementation (5&#x000a0;l containers, containing 5&#x000a0;ml of 0.6&#x000a0;mol&#x000a0;l<sup>&#x02212;1</sup> thymol solution). Urine volume was recorded and following mixing; an aliquot was removed and stored at &#x02212;80&#x000a0;&#x000b0;C for future HPLC analysis of urinary Cr and creatinine content (Dunnett et al. 1991).</p></sec><sec id="Sec7"><title>Muscle sample treatment and analysis</title><p>All biopsy samples were divided into two equal portions under liquid nitrogen. Subsequently, one portion was freeze-dried, dissected free from visible blood and connective tissue and powdered. Total muscle water content of samples was determined by weighing the samples before and after freeze-drying. Freeze-dried samples were then extracted in 0.5&#x000a0;M perchloric acid containing 1&#x000a0;mmol EDTA, with the resulting supernatant neutralised with 2.2&#x000a0;M KHCO<sub>3</sub> and used for the spectrophotometric determination of glucose-6-phosphate (G-6-P), ATP, PCr and Cr (Harris et al. <xref ref-type="bibr" rid="CR30">1974</xref>). Freeze-dried muscle powder was also used for the determination of muscle glycogen (Harris et al. <xref ref-type="bibr" rid="CR30">1974</xref>).</p><p>Total-RNA was extracted from the remaining portion of frozen (wet) muscle using the method of Chomczynski and Sacchi (<xref ref-type="bibr" rid="CR10">1987</xref>) and quantified using a kit (Molecular Probes RNA quantification reagent and kit, Cambridge BioScience, Cambridge, UK). Following this, 3&#x000a0;&#x000b5;l of total-RNA was diluted in 0.05&#x000a0;&#x000b5;g&#x000a0;&#x000b5;l<sup>&#x02212;1</sup> RNA solution for the subsequent analysis of gene expression.</p><p>Following this, 0.5&#x000a0;&#x000b5;g of RNA was added to an Eppendorf tube containing random-hexamers (Promega, Southampton, UK) and RNase-free water, mixed and incubated within a thermal cycler (Mastercycler<sup>&#x000ae;</sup> Gradient, Eppendorf, Hamburg, Germany) for 5&#x000a0;min at 70&#x000a0;&#x000b0;C and then placed on ice. Reverse transcriptase buffer, dATP, dCTP, dGTP, dTTP and dUTP mix, ribonuclease inhibitor, MMLV reverse transcriptase (Promega, Southampton, UK) and RNase-free water were then added to each sample. Samples were then mixed and incubated at 42&#x000a0;&#x000b0;C for 1&#x000a0;h. Following incubation, &#x003b1;-actin, GLUT4, <italic>c</italic>-<italic>fos</italic> and HSP72 mRNA was quantified by real-time PCR using an ABI PRISM 7700 Sequence Detector (Applied Biosystems, Warrington, UK). Probes and primers were designed using Primer Express&#x02122; software Version 2.0 (Applied Biosystems, Warrington, UK; Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), and all samples were run in triplicate. Results were expressed as ratios towards &#x003b1;-actin, which was considered an endogenous mRNA control allowing variation due to RNA extraction as well as RT (cycle times) efficiencies to be taken into account. Final normalising involved attributing a value of 100&#x000a0;% to the average of the triplicate of determinations for the pre-supplementation (post-exercise) time point.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Sequences of forward primers, reverse primers, probes and the GenBank/EMBL accession numbers of genes of interest investigated using real-time polymerase chain reaction technology</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene of interest</th><th align="left">Accession number</th><th align="left">Forward primer (5&#x02032;&#x02013;3&#x02032;)</th><th align="left">Reverse primer (5&#x02032;&#x02013;3<bold>&#x02032;</bold>)</th><th align="left">Probe (5&#x02032;-FAM to 3&#x02032;TAMRA)</th></tr></thead><tbody><tr><td align="left">&#x003b1;-Actin</td><td align="left">J00068</td><td align="left">GTGGCCCTGGACTTCGAG</td><td align="left">TTGCCGATGGTGATGACCT</td><td align="left">N/A (<italic>SYBR</italic>
<sup><italic>&#x000ae;</italic></sup>
<italic>Green Master Mix</italic>)</td></tr><tr><td align="left">GLUT4</td><td align="left">HSIRG7</td><td align="left">CCCACTCTCCCCTCCCTCTTCA</td><td align="left">TCCAATCCCCCTTCTCTAGCA</td><td align="left">TCCTCCCCACCTTCCCCAGACTCA</td></tr><tr><td align="left">
<italic>c</italic>-<italic>fos</italic>
</td><td align="left">ACM16287</td><td align="left">CTTCCTGTTCCCAGCATCATC</td><td align="left">GGCTCCCAGTCTGCTGCATA</td><td align="left">CCGCTCCGTGCCAGACATGGAC</td></tr><tr><td align="left">HSP72</td><td align="left">M11717</td><td align="left">ACCAAGCAGACGCAGATCTTC</td><td align="left">GCCCTCGTACACCTGGATCA</td><td align="left">CCTACTCCGACAACCAACCCGGG</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Calculations and statistics</title><p>All data are reported as means&#x000a0;&#x000b1;&#x000a0;SEM. Comparisons between treatments, for both absolute concentrations and changes from basal, were carried out using the two-way analysis of variance (ANOVA) with repeated measures. When a significant <italic>F</italic> value was obtained (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), an <italic>LSD</italic> post hoc test was used to locate any differences (SPSS Base 8.0). Significance was accepted at the 5&#x000a0;% level, unless otherwise stated in the text.</p><p>With the exception of lactate, the content of all muscle metabolites was adjusted to the mean ATP concentration within each individual (based upon four biopsy samples). By this means, it was possible to compensate for any admixture of connective tissue and other non-muscular elements within each muscle biopsy sample (Harris et al. <xref ref-type="bibr" rid="CR31">1992</xref>).</p><p>Glucose, lactate, insulin and non-esterified fatty acid data (NEFA), shown as area under the curve, were calculated from the individual glucose, lactate, serum insulin and NEFA blood concentrations of each subject at ~15&#x000a0;min intervals (0, 15, 30, 45, 60, 80, 100 and 120&#x000a0;min) during the 120&#x000a0;min of the oral-GTT on the treatment days indicated (Kaleidagraph, Synergy Software, Reading, USA).</p></sec></sec><sec id="Sec9"><title>Results</title><p>Subjects reported compliance with all exercise, supplementation and dietary aspects of the study and did not report any ill effects. Maximal oxygen uptake, daily energy intake and dietary composition were identical between treatment groups (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Urinary Cr excretion was negligible during the first 24&#x000a0;h of placebo supplementation. However, Cr excretion increased dramatically during day 1 of Cr supplementation and was significantly greater than that observed in the placebo group (Cr 0&#x02013;24&#x000a0;h&#x000a0;=&#x000a0;7.6&#x000a0;&#x000b1;&#x000a0;1.5&#x000a0;g vs. placebo 0&#x02013;24&#x000a0;h&#x000a0;=&#x000a0;0.0&#x000a0;&#x000b1;&#x000a0;0.4&#x000a0;g; <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01), pointing to ~60&#x000a0;% of the 20&#x000a0;g Cr ingested being retained by the body during the first 24&#x000a0;h of supplementation. No differences in urinary creatinine excretion existed between groups during the first day of Cr or placebo supplementation (Cr 0&#x02013;24&#x000a0;h&#x000a0;=&#x000a0;1.2&#x000a0;&#x000b1;&#x000a0;0.3&#x000a0;g vs. placebo 0&#x02013;24&#x000a0;h&#x000a0;=&#x000a0;0.9&#x000a0;&#x000b1;&#x000a0;0.3).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Peak oxygen consumption (<italic>V</italic>O<sub>2peak</sub>), daily energy intake and dietary composition of the placebo (glycine) and creatine treatment groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;7)</th><th align="left">Creatine (<italic>n</italic>&#x000a0;=&#x000a0;7)</th></tr></thead><tbody><tr><td align="left">
<italic>V</italic>O<sub>2peak</sub> (ml&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;min<sup>&#x02212;1</sup>)</td><td char="&#x000b1;" align="char">45.9&#x000a0;&#x000b1;&#x000a0;2.3</td><td char="&#x000b1;" align="char">42.9&#x000a0;&#x000b1;&#x000a0;2.0</td></tr><tr><td align="left">Energy intake (kcal&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>)</td><td char="&#x000b1;" align="char">37.6&#x000a0;&#x000b1;&#x000a0;0.0</td><td char="&#x000b1;" align="char">37.5&#x000a0;&#x000b1;&#x000a0;0.0</td></tr><tr><td align="left">Carbohydrate (g&#x000a0;kg<sup>&#x02212;1</sup>&#x000a0;day<sup>&#x02212;1</sup>)</td><td char="&#x000b1;" align="char">8.1&#x000a0;&#x000b1;&#x000a0;0.0</td><td char="&#x000b1;" align="char">8.2&#x000a0;&#x000b1;&#x000a0;0.1</td></tr><tr><td align="left">Carbohydrate (% of calories)</td><td char="&#x000b1;" align="char">80.8&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">81.9&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td align="left">Protein (% of calories)</td><td char="&#x000b1;" align="char">13.5&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">13.0&#x000a0;&#x000b1;&#x000a0;0.3</td></tr><tr><td align="left">Fat (% of calories)</td><td char="&#x000b1;" align="char">7.5&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">7.0&#x000a0;&#x000b1;&#x000a0;0.4</td></tr></tbody></table><table-wrap-foot><p>Values expressed as mean&#x000a0;&#x000b1;&#x000a0;SEM</p></table-wrap-foot></table-wrap></p><p>No difference in muscle water content from pre-supplementation (post-exhaustive exercise) existed within or between treatment groups throughout 6&#x000a0;days of placebo or Cr supplementation (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Muscle water content and metabolite concentrations in exercised human vastus lateralis muscle before (exhaustion) and after 1, 3 and 6&#x000a0;days of creatine&#x000a0;+&#x000a0;carbohydrate (<italic>n</italic>&#x000a0;=&#x000a0;7) or placebo&#x000a0;+&#x000a0;carbohydrate (<italic>n</italic>&#x000a0;=&#x000a0;7) supplementation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Metabolite</th><th align="left">Treatment</th><th align="left">Exhaustion</th><th align="left">1 Day</th><th align="left">3 Days</th><th align="left">6 Days</th></tr></thead><tbody><tr><td align="left" rowspan="2">[H<sub>2</sub>O]</td><td align="left">Placebo</td><td char="&#x000b1;" align="char">77.4&#x000a0;&#x000b1;&#x000a0;0.9</td><td char="&#x000b1;" align="char">79.4&#x000a0;&#x000b1;&#x000a0;2.4</td><td align="left">78.0&#x000a0;&#x000b1;&#x000a0;1.8</td><td align="left">81.4&#x000a0;&#x000b1;&#x000a0;2.9</td></tr><tr><td align="left">Creatine</td><td char="&#x000b1;" align="char">80.5&#x000a0;&#x000b1;&#x000a0;2.0</td><td char="&#x000b1;" align="char">81.8&#x000a0;&#x000b1;&#x000a0;2.0</td><td align="left">78.1&#x000a0;&#x000b1;&#x000a0;1.2</td><td align="left">77.4&#x000a0;&#x000b1;&#x000a0;1.0</td></tr><tr><td align="left" rowspan="2">[ATP]</td><td align="left">Placebo</td><td char="&#x000b1;" align="char">24.9&#x000a0;&#x000b1;&#x000a0;0.8</td><td char="&#x000b1;" align="char">24.6&#x000a0;&#x000b1;&#x000a0;0.9</td><td align="left">23.6&#x000a0;&#x000b1;&#x000a0;0.9</td><td align="left">23.3&#x000a0;&#x000b1;&#x000a0;0.9</td></tr><tr><td align="left">Creatine</td><td char="&#x000b1;" align="char">24.2&#x000a0;&#x000b1;&#x000a0;1.0</td><td char="&#x000b1;" align="char">23.8&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="left">24.8&#x000a0;&#x000b1;&#x000a0;0.9</td><td align="left">24.8&#x000a0;&#x000b1;&#x000a0;0.7</td></tr><tr><td align="left" rowspan="2">[G-6-P]</td><td align="left">Placebo</td><td char="&#x000b1;" align="char">4.4&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">4.6&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">5.8&#x000a0;&#x000b1;&#x000a0;1.9</td><td align="left">5.2&#x000a0;&#x000b1;&#x000a0;3.1</td></tr><tr><td align="left">Creatine</td><td char="&#x000b1;" align="char">4.8&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">3.6&#x000a0;&#x000b1;&#x000a0;0.6</td><td align="left">4.1&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="left">5.2&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td align="left" rowspan="2">[PCr]</td><td align="left">Placebo</td><td char="&#x000b1;" align="char">86.9&#x000a0;&#x000b1;&#x000a0;2.4</td><td char="&#x000b1;" align="char">87.0&#x000a0;&#x000b1;&#x000a0;2.3</td><td align="left">87.8&#x000a0;&#x000b1;&#x000a0;2.1</td><td align="left">85.1&#x000a0;&#x000b1;&#x000a0;3.0</td></tr><tr><td align="left">Creatine</td><td char="&#x000b1;" align="char">84.5&#x000a0;&#x000b1;&#x000a0;4.5</td><td char="&#x000b1;" align="char">91.8&#x000a0;&#x000b1;&#x000a0;2.5</td><td align="left">93.1&#x000a0;&#x000b1;&#x000a0;2.5<sup>&#x02020;</sup>
</td><td align="left">98.7&#x000a0;&#x000b1;&#x000a0;2.5<sup>&#x02020;&#x02020;</sup>**</td></tr><tr><td align="left" rowspan="2">[Creatine]</td><td align="left">Placebo</td><td char="&#x000b1;" align="char">41.1&#x000a0;&#x000b1;&#x000a0;2.1</td><td char="&#x000b1;" align="char">41.0&#x000a0;&#x000b1;&#x000a0;2.1</td><td align="left">43.1&#x000a0;&#x000b1;&#x000a0;1.7</td><td align="left">43.9&#x000a0;&#x000b1;&#x000a0;2.3</td></tr><tr><td align="left">Creatine</td><td char="&#x000b1;" align="char">42.6&#x000a0;&#x000b1;&#x000a0;1.8</td><td char="&#x000b1;" align="char">46.3&#x000a0;&#x000b1;&#x000a0;2.0</td><td align="left">51.7&#x000a0;&#x000b1;&#x000a0;0.8<sup>&#x02020;&#x02020;</sup>**</td><td align="left">59.2&#x000a0;&#x000b1;&#x000a0;2.4<sup>&#x02020;&#x02020;</sup>**</td></tr></tbody></table><table-wrap-foot><p>All values are expressed as means&#x000a0;&#x000b1;&#x000a0;SEM. Muscle water content expressed as a percentage of the total muscle sample weight. Muscle ATP, glucose-6-phosphate (G-6-P), phosphocreatine (PCr) and creatine are expressed as mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle (with the exception of lactate, the content of all muscle metabolites was adjusted to the mean ATP concentration within each individual (based upon four biopsy samples)</p></table-wrap-foot></table-wrap></p><sec id="Sec10"><title>Muscle metabolites</title><p>No change in muscle ATP or G-6-P content was observed from the pre-supplementation (post-exercise) time point during 6&#x000a0;days of Cr and placebo supplementation (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Similarly, no differences in muscle ATP and G-6-P content existed between treatment groups over the time-course of the study (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).</p><p>No significant change in muscle PCr, free-Cr or total-Cr content over time from the pre-supplementation time point was observed with placebo supplementation (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). There was a 17&#x000a0;% significant increase in muscle PCr content from the pre-supplementation value following 3&#x000a0;days of Cr supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), which increased further following 6&#x000a0;days of Cr ingestion (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Creatine ingestion increased muscle PCr content above placebo following 6&#x000a0;days of supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Similarly, Cr ingestion increased muscle free-Cr content following 3&#x000a0;days of supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>), which was 39&#x000a0;% (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) greater than the pre-supplementation value after 6&#x000a0;days of Cr ingestion (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Creatine ingestion increased muscle free-Cr content above placebo after 3&#x000a0;days of supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01), which continued to increase to 35&#x000a0;% greater than placebo following 6&#x000a0;days of Cr ingestion (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).</p><p>In accordance with these changes, muscle total-Cr content was greater than the pre-supplementation value following 1 (9&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), 3 (14&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) and 6 (24&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) days of ingestion (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Creatine ingestion increased muscle total-Cr content above placebo after 1 (8&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), 3 (11&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) and 6 (22&#x000a0;%, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) days of Cr ingestion (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Skeletal muscle total-creatine (TCr) content during 6&#x000a0;days of creatine&#x000a0;+&#x000a0;carbohydrate (Creatine, <italic>n</italic>&#x000a0;=&#x000a0;7) or glycine&#x000a0;+&#x000a0;carbohydrate (Placebo, <italic>n</italic>&#x000a0;=&#x000a0;7) supplementation following glycogen-depleting exercise in man. Results are expressed as means&#x000a0;&#x000b1;&#x000a0;SEM with units of mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle. Different from the pre-supplementation time point (post-exercise, time 0) within the same treatment group (<sup>&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, <sup>&#x02020;&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01); different from placebo at the corresponding time point (*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01)</p></caption><graphic xlink:href="726_2016_2252_Fig2_HTML" id="MO2"/></fig></p><p>No alteration in the PCr:Cr ratio occurred throughout the study in the placebo group. However, the PCr:Cr ratio was lower than the pre-supplementation value (2.00&#x000a0;&#x000b1;&#x000a0;0.13) after 3&#x000a0;days Cr supplementation (1.81&#x000a0;&#x000b1;&#x000a0;0.06, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). This value was also lower than that recorded in the placebo group after 3&#x000a0;days supplementation (2.05&#x000a0;&#x000b1;&#x000a0;0.03, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05).</p><p>The exercise intervention markedly reduced skeletal muscle glycogen content from the habitual resting value of ~400&#x02013;450&#x000a0;mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle, and there was no difference in the post-exercise value between treatment groups immediately prior to Cr and placebo ingestion (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Muscle glycogen content increased dramatically in both treatment groups during 6&#x000a0;days of supplementation, and as expected muscle glycogen content was greater than the post-exercise value in both treatment group following 1, 3 and 6&#x000a0;days (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). However, Cr supplementation increased muscle glycogen content significantly above placebo after 1 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) and 6 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01) days (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), with the augmentation of glycogen storage being almost exclusively confined to the initial 24&#x000a0;h of Cr supplementation, and the difference between treatments being maintained thereafter (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Indeed, the magnitude of glycogen re-synthesis during the first 24&#x000a0;h of supplementation was ~82&#x000a0;% greater in the Cr group compared to placebo (Cr 410&#x000a0;&#x000b1;&#x000a0;50 vs. placebo 225&#x000a0;&#x000b1;&#x000a0;50&#x000a0;mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01), with no difference in the rate of glycogen synthesis existing between groups between 1 and 6&#x000a0;days of supplementation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Skeletal muscle glycogen content during 6&#x000a0;days of creatine&#x000a0;+&#x000a0;carbohydrate (Creatine, <italic>n</italic>&#x000a0;=&#x000a0;7) or glycine&#x000a0;+&#x000a0;carbohydrate (Placebo, <italic>n</italic>&#x000a0;=&#x000a0;7) supplementation following glycogen-depleting exercise in man. Results are expressed as means&#x000a0;&#x000b1;&#x000a0;SEM with units of mmol&#x000a0;kg<sup>&#x02212;1</sup> dry muscle. Different from the pre-supplementation (post-exercise, time 0) time point within the same treatment group (<sup>&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, <sup>&#x02020;&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01); different from placebo at the corresponding time point (*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01)</p></caption><graphic xlink:href="726_2016_2252_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec11"><title>Blood metabolites and oral-glucose tolerance tests</title><p>The area under the blood glucose-time curve during the oral-GTT (defined in Methods) was unchanged from the pre-supplementation value throughout 6&#x000a0;days of placebo ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). Creatine supplementation transiently elevated the area under the glucose curve from basal after 1&#x000a0;day of ingestion (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a), but no differences in the area under the curve existed between treatment groups at any time point throughout the study (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Area under the curve during an oral glucose tolerance test (GTT) for blood glucose (<bold>a</bold>), serum insulin (<bold>b</bold>) and blood lactate (<bold>c</bold>) before (pre-exercise) and after 1, 3 and 6&#x000a0;days of Cr&#x000a0;+&#x000a0;carbohydrate or glycine&#x000a0;+&#x000a0;carbohydrate supplementation following glycogen-depleting exercise in man. Results are expressed as means&#x000a0;&#x000b1;&#x000a0;SEM. Area under plasma glucose and lactate curve expressed as (mmol&#x000a0;l<sup>&#x02212;1</sup>&#x000a0;min<sup>&#x02212;1</sup>), area under serum insulin curve expressed as (mU&#x000a0;l<sup>&#x02212;1</sup>&#x000a0;min<sup>&#x02212;1</sup>). <italic>&#x02020;</italic> different from the pre-exercise time point within the same treatment group (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05); <italic>*</italic> different from placebo group at the corresponding time point (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05)</p></caption><graphic xlink:href="726_2016_2252_Fig4_HTML" id="MO4"/></fig></p><p>Neither placebo nor Cr ingestion had an effect on the area under the serum insulin-time curve during the oral-GTT throughout the study (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). Similarly, no difference between treatment groups was observed at any time point during 6&#x000a0;days of ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). There was a weak trend for Cr supplementation to increase the serum insulin concentration above placebo after 1&#x000a0;day of supplementation (Placebo day 1&#x000a0;=&#x000a0;4310&#x000a0;&#x000b1;&#x000a0;642 vs. Cr day 1&#x000a0;=&#x000a0;5995&#x000a0;&#x000b1;&#x000a0;733&#x000a0;mU/l/min, <italic>P</italic>&#x000a0;=&#x000a0;0.11, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b).</p><p>The area under the blood lactate-time curve during the oral-GTT was unchanged from pre-supplementation throughout 6&#x000a0;days of placebo ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). Creatine supplementation increased the area under the blood lactate-time curve from pre-supplementation after 1 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), 3 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05) and 6 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05) days of ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). The area under the blood lactate-time curve was also elevated above placebo after 3 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05) and 6 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05) days of Cr ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c).</p><p>Placebo and Cr supplementation both caused a significant reduction in area under blood non-esterified free fatty acid-time curve during the oral-GTT (data not shown). However, no difference existed between treatment groups at any point over the course of the study.</p></sec><sec id="Sec12"><title>mRNA expression</title><p>No differences in GLUT4 mRNA expression existed between placebo and Cr treatment groups throughout 6&#x000a0;days of supplementation (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). However, GLUT4 mRNA expression increased ~twofold from the post-exercise time point following 1 and 6&#x000a0;days of placebo supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). No alteration in GLUT4 expression was observed from the post-exercise time point throughout 6&#x000a0;days of Cr supplementation (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Percentage change in skeletal muscle GLUT4, <italic>c</italic>-<italic>fos</italic> and HSP72 expression from immediately post-glycogen-depleting exercise (set at 100&#x000a0;%) after 1, 3 and 6&#x000a0;days of creatine&#x000a0;+&#x000a0;carbohydrate (<italic>n</italic>&#x000a0;=&#x000a0;7) or placebo&#x000a0;+&#x000a0;carbohydrate (<italic>n</italic>&#x000a0;=&#x000a0;7) supplementation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">mRNA</th><th align="left">Treatment</th><th align="left">1 Day</th><th align="left">3 Days</th><th align="left">6 Days</th></tr></thead><tbody><tr><td align="left" rowspan="2">GLUT4</td><td align="left">Placebo</td><td align="left">201.8&#x000a0;&#x000b1;&#x000a0;57.2<sup>&#x02020;</sup>
</td><td align="left">164.2&#x000a0;&#x000b1;&#x000a0;43.5</td><td align="left">210.4&#x000a0;&#x000b1;&#x000a0;57.0<sup>&#x02020;</sup>
</td></tr><tr><td align="left">Creatine</td><td align="left">131.6&#x000a0;&#x000b1;&#x000a0;15.7</td><td align="left">134.6&#x000a0;&#x000b1;&#x000a0;32.1</td><td align="left">123.8&#x000a0;&#x000b1;&#x000a0;14.2</td></tr><tr><td align="left" rowspan="2">
<italic>c</italic>-<italic>fos</italic>
</td><td align="left">Placebo</td><td align="left">18.2&#x000a0;&#x000b1;&#x000a0;8.7<sup>&#x02020;&#x02020;</sup>
</td><td align="left">37.5&#x000a0;&#x000b1;&#x000a0;18.0<sup>&#x02020;&#x02020;</sup>
</td><td align="left">20.5&#x000a0;&#x000b1;&#x000a0;10.8<sup>&#x02020;&#x02020;</sup>
</td></tr><tr><td align="left">Creatine</td><td align="left">23.4&#x000a0;&#x000b1;&#x000a0;8.7<sup>&#x02020;&#x02020;</sup>
</td><td align="left">49.1&#x000a0;&#x000b1;&#x000a0;18.3<sup>&#x02020;&#x02020;</sup>
</td><td align="left">26.9&#x000a0;&#x000b1;&#x000a0;16.1<sup>&#x02020;&#x02020;</sup>
</td></tr><tr><td align="left" rowspan="2">HSP72</td><td align="left">Placebo</td><td align="left">74.1&#x000a0;&#x000b1;&#x000a0;15.5</td><td align="left">49.5&#x000a0;&#x000b1;&#x000a0;9.6<sup>&#x02020;</sup>
</td><td align="left">75.4&#x000a0;&#x000b1;&#x000a0;24.6</td></tr><tr><td align="left">Creatine</td><td align="left">71.4&#x000a0;&#x000b1;&#x000a0;18.9</td><td align="left">49.7&#x000a0;&#x000b1;&#x000a0;14.3<sup>&#x02020;</sup>
</td><td align="left">48.6&#x000a0;&#x000b1;&#x000a0;12.9<sup>&#x02020;</sup>
</td></tr></tbody></table><table-wrap-foot><p>Values are means&#x000a0;&#x000b1;&#x000a0;SEM and are relative to the endogenous control (&#x003b1;-actin) mRNA level and expressed as a percentage of the corresponding pre-supplementation value. Different from pre-supplement time point (<sup>&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05, <sup>&#x02020;&#x02020;</sup>
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01)</p></table-wrap-foot></table-wrap></p><p><italic>c</italic>-<italic>fos</italic> mRNA expression was markedly reduced from the post-exercise (pre-supplementation) time point throughout 6&#x000a0;days of supplementation in both treatment groups (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.01; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>) However, no differences in expression were evident between treatment groups throughout the study (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p><p>No differences in HSP72 mRNA expression existed between treatment groups throughout 6&#x000a0;days of supplementation (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). However, HSP72 expression was reduced from the post-exercise time point following 3&#x000a0;days of supplementation in both treatment groups (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). The reduced expression of HSP72 was transient in the placebo group, but was sustained after 6&#x000a0;days of Cr supplementation (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p></sec></sec><sec id="Sec13"><title>Discussion</title><p>The primary aim of the present study was to delineate the time-course of dietary Cr-mediated post-exercise muscle glycogen super-compensation in humans under conditions, where energy intake and food consumption were stringently controlled. The principal finding was that dietary Cr supplementation markedly augmented post-exercise muscle glycogen storage above placebo during a conventional &#x02018;carbohydrate-loading&#x02019; regime, and that this augmentation of glycogen storage occurred almost exclusively within the first 24&#x000a0;h of supplementation (the magnitude of glycogen re-synthesis during the first 24&#x000a0;h of supplementation was ~82&#x000a0;% greater in the Cr group compared to placebo). The results also point to this Cr-induced glycogen super-compensation being independent of the time-course of muscle Cr accumulation and changes in serum insulin availability, insulin sensitivity and/or cellular osmotic stress responses, such that another mechanism(s) must be causative.</p><sec id="Sec14"><title>Muscle creatine and glycogen storage</title><p>Several studies have evaluated muscle glycogen storage in humans in response to acute (20&#x000a0;g&#x000a0;day<sup>&#x02212;1</sup> for 5&#x000a0;days; Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>; Newman et al. <xref ref-type="bibr" rid="CR40">2003</xref>; van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>) and more prolonged Cr ingestion (2.5&#x02013;20&#x000a0;g&#x000a0;day<sup>&#x02212;1</sup> for 8&#x02013;12&#x000a0;weeks; Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>; Derave et al. <xref ref-type="bibr" rid="CR13">2003</xref>). The findings of these studies largely support a role for dietary Cr in enhancing muscle glycogen storage (+12&#x02013;23&#x000a0;%) when ingested following exhaustive exercise (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>), or during 6&#x02013;8&#x000a0;weeks of resistance training (+30&#x02013;35&#x000a0;%; Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>; Derave et al. <xref ref-type="bibr" rid="CR13">2003</xref>). The evidence that dietary Cr ingestion can augment muscle glycogen storage in the non-exercised state is less compelling, with a positive effect (+18&#x000a0;%) being reported by van Loon et al. (<xref ref-type="bibr" rid="CR52">2004</xref>) following 5&#x000a0;days of Cr supplementation, but no effect at all being reported by others (Newman et al. <xref ref-type="bibr" rid="CR40">2003</xref>; Sewell et al. <xref ref-type="bibr" rid="CR47">2008</xref>), even within the same volunteer when one limb has been exercised and the contra-lateral limb has remained inactive (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>). As far as we are aware, the present study is the first to establish the post-exercise glycogen super-compensatory properties of dietary Cr supplementation under rigorously controlled dietary conditions in humans (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) and to document the time-course of this effect. It is clear from the data (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) that the Cr-induced augmentation of muscle glycogen storage occurs not as a gradual bifurcation from the typical glycogen-loading response observed in the placebo group, but rather as a transient marked increase (approximately twofold) in glycogen re-synthesis during the initial 24&#x000a0;h of Cr ingestion during recovery from exercise (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p>It has been suggested that the expansion of the muscle total-Cr pool is a prerequisite for Cr-induced augmentation of muscle glycogen storage (Van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>; Volek and Rawson <xref ref-type="bibr" rid="CR53">2004</xref>). Indeed, work by Van Loon et al. (<xref ref-type="bibr" rid="CR52">2004</xref>) showed a significant correlation between the magnitude of increase in muscle total-Cr (+31&#x000a0;%) and glycogen storage (+18&#x000a0;%) following 5&#x000a0;days of Cr supplementation. This observation was strengthened by the findings from another study of this research group, where the absence of a treatment effect upon glycogen storage was attributed to inadequate muscle Cr accumulation (+12&#x000a0;%; Newman et al. <xref ref-type="bibr" rid="CR40">2003</xref>). However, in neither of these studies were muscle biopsies obtained over the time-course of Cr supplementation. Indeed, as the Cr-mediated augmentation of glycogen storage in the present study occurred almost exclusively within the first 24&#x000a0;h of Cr ingestion, when muscle total-Cr stores had increased by only 8&#x000a0;% (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), the findings clearly do not support the contention that the extent of muscle total-Cr accumulation is an important determinant of the muscle glycogen storage response. Furthermore, following 24&#x000a0;h, no greater muscle glycogen storage above that recorded in the placebo group was observed from days 1 to 6 of Cr ingestion, despite muscle total-Cr increasing by a further 15&#x000a0;% in the Cr supplementation group (Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>).</p><p>It could be speculated that a transient change in the PCr/Cr ratio in response to 24&#x000a0;h of Cr feeding may have blunted the exercise-induced activation of AMPK (Winder and Hardie <xref ref-type="bibr" rid="CR54">1999</xref>; Rasmussen and Winder <xref ref-type="bibr" rid="CR43">1997</xref>; Fujii et al. <xref ref-type="bibr" rid="CR22">2000</xref>), which in turn, and independent of any alteration in muscle insulin sensitivity, could have augmented muscle glycogen synthesis during the initial 24&#x000a0;h of post-exercise recovery by dampening the inhibitory effect of AMPK on glycogen synthase activity (Aschenbach et al. <xref ref-type="bibr" rid="CR1">2002</xref>; Wojtaszewski et al. <xref ref-type="bibr" rid="CR55">2002</xref>; Jorgensen et al. <xref ref-type="bibr" rid="CR35">2004</xref>). Indeed, an alteration in the composition of the muscle Cr pool, as occurs, for example, during exercise and Cr feeding, has been reported to directly impact upon the activation status of AMPK (Ponticos et al. <xref ref-type="bibr" rid="CR41">1998</xref>). The in vitro findings of Ponticos et al. (<xref ref-type="bibr" rid="CR41">1998</xref>) showed that physiological increases in muscle PCr content directly inhibited AMPK activation in a dose-dependent manner. Furthermore, this inhibition was attenuated (indirectly) by an increase in muscle free-Cr content; pointing to the PCr/Cr ratio, along with the ATP/ADP ratio, being a regulator of skeletal muscle AMPK activation status (for review, see Hardie and Hawley <xref ref-type="bibr" rid="CR28">2001</xref>). A reduction in the muscle PCr/Cr ratio has been reported following acute-Cr ingestion (Harris et al. <xref ref-type="bibr" rid="CR31">1992</xref>; Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>), which has prompted researchers to examine the effect of Cr availability on AMPK activation in vitro (Ceddoa and Sweeny <xref ref-type="bibr" rid="CR9">2004</xref>) and in vivo (Ju et al. <xref ref-type="bibr" rid="CR36">2005</xref>; Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR17">2005</xref>). The findings from these studies are equivocal, with AMPK being activated by unphysiological concentrations of PCr and Cr (Ceddoa and Sweeny <xref ref-type="bibr" rid="CR9">2004</xref>), and independent of any alteration in the muscle PCr/Cr ratio (Ju et al. <xref ref-type="bibr" rid="CR36">2005</xref>), in some, but not all, studies (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR17">2005</xref>). In the present in vivo study, Cr ingestion reduced the muscle PCr/Cr ratio from basal following 3&#x000a0;days of supplementation, but this response occurred after the Cr-mediated increase in muscle glycogen storage (0&#x02013;24&#x000a0;h, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), making it unlikely that this underpinned the augmentation of glycogen storage observed between 0 and 24&#x000a0;h. Furthermore, contrary to the report of Ponticos et al. (<xref ref-type="bibr" rid="CR41">1998</xref>), more recent in vitro research has surmised that although the concept of a PCr/Cr ratio mediated regulation of AMP kinase may be intuitive and attractive, evidence to substantiate this concept is not prevalent (Taylor et al. <xref ref-type="bibr" rid="CR51">2006</xref>; Suter et al. <xref ref-type="bibr" rid="CR50">2006</xref>).</p></sec><sec id="Sec15"><title>Muscle creatine and insulin sensitivity</title><p>It is logical to assume that the rapid augmentation of post-exercise glycogen storage that accompanied Cr ingestion (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) would have been preceded by an increase in muscle glucose uptake, which we hoped to demonstrate by performing oral-GTTs and determining muscle GLUT4 mRNA expression (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>) over the course of 6&#x000a0;days of exercise recovery. However, given that the Cr-induced augmentation of muscle glycogen storage occurred almost exclusively within the first 24&#x000a0;h of treatment and, therefore, preceded the first post-exercise oral-GTT (1&#x000a0;day), any effect of Cr ingestion on glucose clearance must have occurred within the initial 24&#x000a0;h of recovery. Indeed, based upon our previous observation (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>), which found no effect of Cr ingestion on muscle glycogen storage during the initial 6&#x000a0;h of recovery from exercise, and the present study that showed a dramatic effect after 24&#x000a0;h of recovery (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), this Cr augmentation of glycogen storage must have occurred between 6 to 24&#x000a0;h of post-exercise recovery. The increase in area under the blood glucose curve during the oral-GTT after 1&#x000a0;day of Cr ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a), and along with the trend for the serum insulin response to do the same (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b), most probably reflects a blunting in muscle glucose uptake caused by the marked increase in muscle glycogen storage over the preceding 24 h. This view is supported by the increase in blood lactate concentration that accompanied Cr ingestion (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c).</p><p>It has been suggested that Cr supplementation can up-regulate muscle GLUT4 protein expression, thereby increasing muscle glucose uptake and underpinning the glycogen super-compensatory properties of Cr supplementation (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>). However, this view is not supported by the findings others (Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR15">2001a</xref>; van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>), where, for example, no increase in muscle GLUT4 mRNA or protein expression was observed in response to acute or prolonged Cr ingestion in healthy human volunteers (van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>). The finding of the present study that Cr ingestion had no influence on muscle GLUT4 mRNA expression (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>) is in concordance with this stance. However, it is acknowledged that the quantification of muscle GLUT4 protein and/or components of the signalling cascade regulating GLUT4 translocation (e.g., AS160 activation) would have provided more robust insight.</p></sec><sec id="Sec16"><title>Muscle cell volume and osmotic stress responses</title><p>Another mechanism that has been suggested to underpin the stimulatory effect of Cr ingestion on acute glycogen super-compensation is an increase in intra-myocellular water content, secondary to an increase in muscle Cr accumulation (Robinson et al. <xref ref-type="bibr" rid="CR44">1999</xref>; Op&#x02019;t Eijnde et al. <xref ref-type="bibr" rid="CR16">2001b</xref>; van Loon et al. <xref ref-type="bibr" rid="CR52">2004</xref>). Indeed, muscle Cr transport is dependent upon extracellular Na<sup>+</sup>, and is, therefore, osmotically active (Daly and Seifter <xref ref-type="bibr" rid="CR11">1980</xref>), with an increase in fat-free body mass and a decrease in urinary volume being reported in response to acute-Cr feeding; indicative of an increase whole-body water retention (Hultman et al. <xref ref-type="bibr" rid="CR33">1996</xref>). It has been demonstrated in vitro that changes in cell volume in rodent muscle can modulate changes in muscle glycogen content, independent of any alteration in cell glucose uptake (Low et al. <xref ref-type="bibr" rid="CR38">1996</xref>). However, although muscle total-Cr (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) and glycogen (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) both increased during the initial 24&#x000a0;h of dietary Cr ingestion in the present study, the time-course of change for each metabolite over the 6&#x000a0;days of supplementation was very different, with the glycogen super-compensatory response being almost exclusively restricted to the initial 24&#x000a0;h of supplementation, whilst muscle total-Cr content increased in a more gradual manner over the study. It is unlikely, therefore, that a Cr-mediated increase in cellular hydration status stimulated this marked initial increase in muscle glycogen storage, such that another mechanism seems likely. This conclusion is supported by the lack of any treatment effect on muscle water content during 6&#x000a0;days of supplementation (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) and by the absence of any differences in mRNA expression of the osmotically induced transcription factors <italic>c</italic>-<italic>fos</italic> and HSP72 between Cr and placebo groups (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Changes in the expression of HSP72 (Febraio et al. <xref ref-type="bibr" rid="CR19">2002</xref>) and <italic>c</italic>-<italic>fos</italic> (Puntschart et al. <xref ref-type="bibr" rid="CR42">1998</xref>) mRNA have been shown to correlate well with changes in their respective protein products, indicating they are at least partly under transcriptional regulation. Furthermore, it has been suggested that muscle HSP72 expression is sensitive to alterations in myofibril glycogen content in man, with HSP72 mRNA increasing in response to glycogen-depleting exercise before gradually being reduced as glycogen stores are replenished (Febbraio and Koukoulas <xref ref-type="bibr" rid="CR18">2000</xref>; Febraio et al. <xref ref-type="bibr" rid="CR19">2002</xref>). Although the present study lacked a pre-exercise muscle biopsy, in support of the findings of Febraio et al. (<xref ref-type="bibr" rid="CR19">2002</xref>), post-exercise HSP72 expression was halved following 3&#x000a0;days of recovery in the Cr and placebo groups, as muscle glycogen was super-compensated (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). However, it is clear that HSP72 mRNA expression was insensitive to the marked differences in muscle glycogen content that existed between treatment groups following 1&#x000a0;day of supplementation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>; Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p><p>In conclusion, we have confirmed the ability of dietary Cr supplementation to augment post-exercise muscle glycogen storage during a conventional and rigorously controlled &#x02018;carbohydrate-loading&#x02019; regimen in humans. Furthermore, this Cr-induced augmentation of muscle glycogen storage occurred almost exclusively within the first 24&#x000a0;h of exercise recovery and Cr ingestion, and appeared to be unrelated to changes in the magnitude of increase in muscle total-Cr, PCr or Cr content, muscle insulin sensitivity, or osmotic stress and muscle cell volume responses, such that another mechanism must be causative.</p></sec></sec></body><back><ack><p>The authors would like to thank Dr Michelle Holdsworth for her help in planning the subject diets and Ms Liz Simpson, Dr Nandini Seevaratman and Dr Kishor Patel for providing additional medical support for the study when required. We also wish to thank a dedicated group of subjects for their participation in this study and Glaxo-Smithkline, Coleford, UK, for providing the Lucozade drinks.</p></ack><notes notes-type="conflict-interest"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Ethical approval</title><p>All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p></sec><sec id="FPar2"><title>Funding</title><p>This work was funded as part of the Chemical Biological Defence and Human Sciences Domain of the UK MoD Corporate Research Programme.</p></sec><sec id="FPar3"><title>Conflict of interest</title><p>The authors declare that they have no conflict of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aschenbach</surname><given-names>WG</given-names></name><name><surname>Hirshman</surname><given-names>MF</given-names></name><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Howlett</surname><given-names>KF</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name></person-group><article-title>Effect of AICAR treatment on glycogen metabolism in skeletal muscle</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.3.567</pub-id><pub-id pub-id-type="pmid">11872652</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>F-X</given-names></name><name><surname>Gr&#x000fc;nbein</surname><given-names>R</given-names></name><name><surname>Lugmayr</surname><given-names>K</given-names></name><name><surname>Neuhofer</surname><given-names>W</given-names></name></person-group><article-title>Heat shock proteins and the cellular response to osmotic stress</article-title><source>Cell Physiol Biochem</source><year>2000</year><volume>10</volume><fpage>303</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1159/000016362</pub-id><pub-id pub-id-type="pmid">11125209</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name></person-group><article-title>Percutaneous needle biopsy of skeletal muscle in physiological and clinical research</article-title><source>Scand J Clin Lab Invest</source><year>1975</year><volume>35</volume><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.3109/00365517509095787</pub-id><pub-id pub-id-type="pmid">1108172</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name></person-group><article-title>Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man</article-title><source>Nature</source><year>1966</year><volume>210</volume><fpage>309</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1038/210309a0</pub-id><pub-id pub-id-type="pmid">5954569</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name></person-group><article-title>A study of glycogen metabolism during exercise in man</article-title><source>Scand J Clin Lab Invest</source><year>1967</year><volume>19</volume><fpage>218</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.3109/00365516709090629</pub-id><pub-id pub-id-type="pmid">6048626</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Hermansen</surname><given-names>L</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name></person-group><article-title>Diet, muscle glycogen and physical performance</article-title><source>Acta Physiol Scand</source><year>1967</year><volume>71</volume><fpage>140</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.1967.tb03720.x</pub-id><pub-id pub-id-type="pmid">5584523</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>GA</given-names></name></person-group><article-title>Psychophysical bases of perceived exertion</article-title><source>Med Sci Sports Exerc</source><year>1982</year><volume>14</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">7154893</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>A</given-names></name><name><surname>Short</surname><given-names>AH</given-names></name><name><surname>Curtis</surname><given-names>S</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>The effect of glycogen availability on power output and the metabolic response to repeated bouts of maximal, isokinetic exercise in man</article-title><source>Eur J Appl Physiol</source><year>1996</year><volume>72</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1007/BF00838647</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceddoa</surname><given-names>RB</given-names></name><name><surname>Sweeny</surname><given-names>G</given-names></name></person-group><article-title>Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells</article-title><source>J Physiol</source><year>2004</year><volume>555</volume><fpage>409</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.056291</pub-id><pub-id pub-id-type="pmid">14724211</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomczynski</surname><given-names>P</given-names></name><name><surname>Sacchi</surname><given-names>N</given-names></name></person-group><article-title>Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction</article-title><source>Anal Biochem</source><year>1987</year><volume>162</volume><fpage>156</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(87)90021-2</pub-id><pub-id pub-id-type="pmid">2440339</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>MM</given-names></name><name><surname>Seifter</surname><given-names>S</given-names></name></person-group><article-title>Uptake of creatine by cultured cells</article-title><source>Arch Biochem Biophys</source><year>1980</year><volume>203</volume><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(80)90182-4</pub-id><pub-id pub-id-type="pmid">7406503</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dentowski</surname><given-names>A</given-names></name><name><surname>Opaszowski</surname><given-names>BH</given-names></name><name><surname>Blanchnio</surname><given-names>D</given-names></name><name><surname>Ponanowski</surname><given-names>B</given-names></name></person-group><article-title>Effect of creatine supplementation on the performance in supra-maximal, intermittent exercise</article-title><source>Biol Sport</source><year>1997</year><volume>14</volume><fpage>291</fpage><lpage>298</lpage></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derave</surname><given-names>W</given-names></name><name><surname>Eijnde</surname><given-names>BO</given-names></name><name><surname>Verbessem</surname><given-names>P</given-names></name><name><surname>Ramaekers</surname><given-names>M</given-names></name><name><surname>Van Leemputte</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name></person-group><article-title>Combined creatine and protein supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans</article-title><source>J Appl Physiol</source><year>2003</year><volume>94</volume><fpage>1910</fpage><lpage>1916</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00977.2002</pub-id><pub-id pub-id-type="pmid">12524381</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunnett</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Orme</surname><given-names>CE</given-names></name></person-group><article-title>Reverse-phase-ion-pairing high-performance liquid chromatography of phosphocreatine, creatine and creatinine in equine muscle</article-title><source>Scand J Clin Lab Investig</source><year>1991</year><volume>51</volume><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1080/00365519109091099</pub-id><pub-id pub-id-type="pmid">2042018</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Febbraio</surname><given-names>MA</given-names></name><name><surname>Koukoulas</surname><given-names>I</given-names></name></person-group><article-title>HSP72 gene expression progressively increases in human skeletal muscle during prolonged, exhaustive exercise</article-title><source>J Appl Physiol</source><year>2000</year><volume>89</volume><fpage>1055</fpage><lpage>1060</lpage><pub-id pub-id-type="pmid">10956350</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Febraio</surname><given-names>MA</given-names></name><name><surname>Steensberg</surname><given-names>A</given-names></name><name><surname>Walsh</surname><given-names>R</given-names></name><name><surname>Koukoulas</surname><given-names>I</given-names></name><name><surname>Van Hall</surname><given-names>G</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group><article-title>Reduced glycogen availability is associated with an elevation in HSP72 in contracting human skeletal muscle</article-title><source>J Physiol</source><year>2002</year><volume>583</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2001.013145</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francaux</surname><given-names>M</given-names></name><name><surname>Poortmans</surname><given-names>JR</given-names></name></person-group><article-title>Effects of training and creatine supplement on muscle strength and body mass</article-title><source>Eur J Appl Physiol</source><year>1999</year><volume>80</volume><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1007/s004210050575</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>LGD</given-names></name><name><surname>Foufelle</surname><given-names>F</given-names></name><name><surname>Baines</surname><given-names>K</given-names></name><name><surname>Baldwin</surname><given-names>SA</given-names></name><name><surname>Woods</surname><given-names>A</given-names></name><name><surname>Carling</surname><given-names>D</given-names></name></person-group><article-title>Characterisation of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells</article-title><source>Biochem J</source><year>2002</year><volume>363</volume><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1042/bj3630167</pub-id><pub-id pub-id-type="pmid">11903059</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Hirshman</surname><given-names>MF</given-names></name><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>Habinowski</surname><given-names>SA</given-names></name><name><surname>Kaijser</surname><given-names>L</given-names></name><name><surname>Mu</surname><given-names>J</given-names></name><name><surname>Ljungqvist</surname><given-names>O</given-names></name><name><surname>Birnhaum</surname><given-names>MJ</given-names></name><name><surname>Witters</surname><given-names>LA</given-names></name><name><surname>Thorell</surname><given-names>A</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name></person-group><article-title>Exercise induces isoform-specific increase in 5&#x02032;AMP-activated protein kinase activity in human skeletal muscle</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>273</volume><fpage>1150</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.3073</pub-id><pub-id pub-id-type="pmid">10891387</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallen</surname><given-names>IW</given-names></name><name><surname>Macdonald</surname><given-names>IA</given-names></name></person-group><article-title>Effect of two methods of hand heating on body temperature, forearm blood flow, and deep venous oxygen saturation</article-title><source>Am J Physiol</source><year>1990</year><volume>259</volume><fpage>E639</fpage><lpage>E643</lpage><pub-id pub-id-type="pmid">2240202</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>AL</given-names></name><name><surname>Simpson</surname><given-names>EJ</given-names></name><name><surname>Littlewood</surname><given-names>JJ</given-names></name><name><surname>Macdonald</surname><given-names>IA</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Carbohydrate ingestion augments creatine retention during creatine feeding in humans</article-title><source>Acta Physiologica Scandinavia</source><year>1996</year><volume>158</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201X.1996.528300000.x</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>AL</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name><name><surname>Macdonald</surname><given-names>IA</given-names></name><name><surname>Sewell</surname><given-names>DA</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans</article-title><source>Am J Physiol</source><year>1996</year><volume>271</volume><fpage>E821</fpage><lpage>E826</lpage><pub-id pub-id-type="pmid">8944667</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhaff</surname><given-names>PL</given-names></name><name><surname>Casey</surname><given-names>A</given-names></name><name><surname>Short</surname><given-names>AH</given-names></name><name><surname>Harris</surname><given-names>R</given-names></name><name><surname>S&#x000f6;derlund</surname><given-names>K</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name></person-group><article-title>The influence of oral creatine supplementation on muscle torque during repeated bouts of maximal voluntary exercise in man</article-title><source>Clin Sci</source><year>1993</year><volume>84</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1042/cs0840565</pub-id><pub-id pub-id-type="pmid">8504634</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhaff</surname><given-names>PL</given-names></name><name><surname>Bodin</surname><given-names>K</given-names></name><name><surname>S&#x000f6;derlund</surname><given-names>K</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name></person-group><article-title>The effect of oral creatine supplementation on skeletal muscle phosphocreatine re-synthesis</article-title><source>Am J Physiol</source><year>1994</year><volume>266</volume><fpage>E725</fpage><lpage>E730</lpage><pub-id pub-id-type="pmid">8203511</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name></person-group><article-title>AMP-activated protein kinase: the energy charge hypothesis revisited</article-title><source>BioEssays</source><year>2001</year><volume>23</volume><fpage>1112</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.1002/bies.10009</pub-id><pub-id pub-id-type="pmid">11746230</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>AMP-activated protein kinase: a key system mediating metabolic responses to exercise</article-title><source>Med Sci Sports Exerc</source><year>2004</year><volume>36</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000106171.38299.64</pub-id><pub-id pub-id-type="pmid">14707764</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name><name><surname>Nordesj&#x000f6;</surname><given-names>LO</given-names></name></person-group><article-title>Glycogen, glycolytic intermediates and high energy phosphates determined in biopsy samples of musculus femoris of man at rest. Methods in variance values</article-title><source>Scand J Clin Lab Invest</source><year>1974</year><volume>33</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.3109/00365517409082477</pub-id><pub-id pub-id-type="pmid">4852173</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>S&#x000f6;durlund</surname><given-names>K</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name></person-group><article-title>Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation</article-title><source>Clin Sci</source><year>1992</year><volume>83</volume><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1042/cs0830367</pub-id><pub-id pub-id-type="pmid">1327657</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Hirshman</surname><given-names>MF</given-names></name><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Haninowski</surname><given-names>SA</given-names></name><name><surname>Witters</surname><given-names>LA</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name></person-group><article-title>Metabolic stress and altered glucose transport activation of AMP-activated protein kinase as a unifying coupling mechanism</article-title><source>Diabetes</source><year>2000</year><volume>49</volume><fpage>527</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.2337/diabetes.49.4.527</pub-id><pub-id pub-id-type="pmid">10871188</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hultman</surname><given-names>E</given-names></name><name><surname>S&#x000f6;derlund</surname><given-names>K</given-names></name><name><surname>Timmons</surname><given-names>JA</given-names></name><name><surname>Cederlad</surname><given-names>G</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Muscle creatine loading in man</article-title><source>J Appl Physiol</source><year>1996</year><volume>81</volume><fpage>232</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">8828669</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jentjens</surname><given-names>R</given-names></name><name><surname>Jeukendrup</surname><given-names>AE</given-names></name></person-group><article-title>Determinants of post-exercise glycogen synthesis during short-term recovery</article-title><source>Sports Med</source><year>2003</year><volume>33</volume><fpage>117</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.2165/00007256-200333020-00004</pub-id><pub-id pub-id-type="pmid">12617691</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>SB</given-names></name><name><surname>Nielsen</surname><given-names>JN</given-names></name><name><surname>Birk</surname><given-names>JB</given-names></name><name><surname>Olsen</surname><given-names>GS</given-names></name><name><surname>Viollet</surname><given-names>B</given-names></name><name><surname>Andreelli</surname><given-names>F</given-names></name><name><surname>Schjerling</surname><given-names>P</given-names></name><name><surname>Vaulont</surname><given-names>S</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Hansen</surname><given-names>BF</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Wojtaszewski</surname><given-names>JFP</given-names></name></person-group><article-title>The &#x003b1;2&#x02013;5&#x02032;AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>3074</fpage><lpage>3081</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.12.3074</pub-id><pub-id pub-id-type="pmid">15561936</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>J-S</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name><name><surname>Oppelt</surname><given-names>PJ</given-names></name><name><surname>Fisher</surname><given-names>JS</given-names></name></person-group><article-title>Creatine feeding increases GLUT4 expression in rat skeletal muscle</article-title><source>Am J Physiol</source><year>2005</year><volume>288</volume><fpage>E347</fpage><lpage>E352</lpage></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>M</given-names></name></person-group><article-title>The cellular stress response to exercise: role of stress proteins</article-title><source>Exerc Sports Sci Rev</source><year>1997</year><volume>25</volume><fpage>105</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1249/00003677-199700250-00007</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>SY</given-names></name><name><surname>Rennie</surname><given-names>MJ</given-names></name><name><surname>Taylor</surname><given-names>PM</given-names></name></person-group><article-title>Modulation of glycogen synthesis in rat skeletal muscle by changes in cell volume</article-title><source>J Physiol</source><year>1996</year><volume>495</volume><fpage>299</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1996.sp021594</pub-id><pub-id pub-id-type="pmid">8887744</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murton</surname><given-names>AJ</given-names></name><name><surname>Billeter</surname><given-names>R</given-names></name><name><surname>Stephens</surname><given-names>FB</given-names></name><name><surname>Des Etages</surname><given-names>SG</given-names></name><name><surname>Graber</surname><given-names>F</given-names></name><name><surname>Hill</surname><given-names>RJ</given-names></name><name><surname>Marimuthu</surname><given-names>K</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Transient transcriptional events in human skeletal muscle at the outset of concentric resistance exercise training</article-title><source>J Appl Physiol</source><year>2014</year><volume>116</volume><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00426.2013</pub-id><pub-id pub-id-type="pmid">24265280</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>JE</given-names></name><name><surname>Hargreaves</surname><given-names>M</given-names></name><name><surname>Garnham</surname><given-names>A</given-names></name><name><surname>Snow</surname><given-names>RJ</given-names></name></person-group><article-title>Effect of creatine ingestion on glucose tolerance and insulin sensitivity in men</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1097/00005768-200301000-00012</pub-id><pub-id pub-id-type="pmid">12544638</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Op&#x02019;t Eijnde</surname><given-names>B</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Henquin</surname><given-names>J-C</given-names></name><name><surname>Kiens</surname><given-names>B</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name></person-group><article-title>Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle</article-title><source>Acta Physiologica Scandinavia</source><year>2001</year><volume>171</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201x.2001.00786.x</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Op&#x02019;t Eijnde</surname><given-names>B</given-names></name><name><surname>Urso</surname><given-names>B</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name></person-group><article-title>Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.1.18</pub-id><pub-id pub-id-type="pmid">11147785</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Op&#x02019;t Eijnde</surname><given-names>B</given-names></name><name><surname>Derave</surname><given-names>W</given-names></name><name><surname>Wojtaszewski</surname><given-names>JFP</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name></person-group><article-title>AMP-kinase expression and activity in human skeletal muscle: effects of immobilisation, retraining and creatine supplementation</article-title><source>J Appl Physiol</source><year>2005</year><volume>98</volume><fpage>1228</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00665.2004</pub-id><pub-id pub-id-type="pmid">15516364</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponticos</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>LuQ</given-names></name><name><surname>Morgan</surname><given-names>JE</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Partridge</surname><given-names>TA</given-names></name><name><surname>Carling</surname><given-names>D</given-names></name></person-group><article-title>Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>1688</fpage><lpage>1699</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.6.1688</pub-id><pub-id pub-id-type="pmid">9501090</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puntschart</surname><given-names>A</given-names></name><name><surname>Wey</surname><given-names>E</given-names></name><name><surname>Jostarndt</surname><given-names>K</given-names></name><name><surname>Vogt</surname><given-names>M</given-names></name><name><surname>Wittwer</surname><given-names>M</given-names></name><name><surname>Widmer</surname><given-names>HR</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Billeter</surname><given-names>R</given-names></name></person-group><article-title>Expression of fos and jun genes in human skeletal muscle after exercise</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>C129</fpage><lpage>C137</lpage><pub-id pub-id-type="pmid">9458721</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>BB</given-names></name><name><surname>Winder</surname><given-names>WW</given-names></name></person-group><article-title>Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase</article-title><source>J Appl Physiol</source><year>1997</year><volume>83</volume><fpage>1104</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">9338417</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>TM</given-names></name><name><surname>Sewell</surname><given-names>DA</given-names></name><name><surname>Hultman</surname><given-names>E</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Role of submaximal exercise in promoting creatine and glycogen accumulation in human skeletal muscle</article-title><source>J Appl Physiol</source><year>1999</year><volume>87</volume><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">10444618</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>TM</given-names></name><name><surname>Sewell</surname><given-names>DA</given-names></name><name><surname>Casey</surname><given-names>A</given-names></name><name><surname>Steenage</surname><given-names>G</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function</article-title><source>Br J Sports Med</source><year>2000</year><volume>34</volume><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1136/bjsm.34.4.284</pub-id><pub-id pub-id-type="pmid">10953902</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadoshima</surname><given-names>J</given-names></name><name><surname>Izumo</surname><given-names>S</given-names></name></person-group><article-title>Tyrosine kinases mediation of c-fos expression by cell swelling in cardiac myocytes</article-title><source>Heart Vessels</source><year>1997</year><volume>12</volume><fpage>194</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">9476581</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sewell</surname><given-names>DA</given-names></name><name><surname>Robinson</surname><given-names>TM</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Creatine supplementation does not affect human skeletal muscle glycogen content in the absence of prior exercise</article-title><source>J Appl Physiol</source><year>2008</year><volume>104</volume><fpage>508</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00787.2007</pub-id><pub-id pub-id-type="pmid">18032580</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>WM</given-names></name><name><surname>Costill</surname><given-names>DL</given-names></name></person-group><article-title>The marathon: dietary manipulation to optimize performance</article-title><source>Am J Sports Med</source><year>1984</year><volume>12</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1177/036354658401200107</pub-id><pub-id pub-id-type="pmid">6367502</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>GR</given-names></name><name><surname>Watt</surname><given-names>MJ</given-names></name><name><surname>McGee</surname><given-names>SL</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Hargreaves</surname><given-names>M</given-names></name><name><surname>Febbraio</surname><given-names>MA</given-names></name><name><surname>Stapleton</surname><given-names>D</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name></person-group><article-title>Reduced glycogen availability is associated with increased AMPKalpha2 activity, nuclear AMPKalpha2 protein abundance, and GLUT4 mRNA expression in contracting human skeletal muscle</article-title><source>Appl Physiol Nutr Metab</source><year>2006</year><volume>31</volume><fpage>302</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1139/h06-003</pub-id><pub-id pub-id-type="pmid">16770359</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suter</surname><given-names>M</given-names></name><name><surname>Riek</surname><given-names>U</given-names></name><name><surname>Tuerk</surname><given-names>R</given-names></name><name><surname>Schlattner</surname><given-names>U</given-names></name><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Neumann</surname><given-names>D</given-names></name></person-group><article-title>Dissecting the role of 5&#x02019;-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>32207</fpage><lpage>32216</lpage><pub-id pub-id-type="doi">10.1074/jbc.M606357200</pub-id><pub-id pub-id-type="pmid">16943194</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>EB</given-names></name><name><surname>Ellingson</surname><given-names>WJ</given-names></name><name><surname>Lamb</surname><given-names>JD</given-names></name><name><surname>Chesser</surname><given-names>DG</given-names></name><name><surname>Compton</surname><given-names>CL</given-names></name><name><surname>Winder</surname><given-names>WW</given-names></name></person-group><article-title>Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate</article-title><source>Am J Physiol</source><year>2006</year><volume>290</volume><fpage>E661</fpage><lpage>E669</lpage></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Loon</surname><given-names>LJC</given-names></name><name><surname>Murphy</surname><given-names>R</given-names></name><name><surname>Oosterlaar</surname><given-names>AM</given-names></name><name><surname>Cameron-Smith</surname><given-names>D</given-names></name><name><surname>Hargreaves</surname><given-names>M</given-names></name><name><surname>Wagonmakers</surname><given-names>AJM</given-names></name><name><surname>Snow</surname><given-names>R</given-names></name></person-group><article-title>Creatine supplementation increases glycogen storage but not GLUT-4 expression in human skeletal muscle</article-title><source>Clin Sci</source><year>2004</year><volume>106</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1042/CS20030116</pub-id><pub-id pub-id-type="pmid">14507259</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volek</surname><given-names>JS</given-names></name><name><surname>Rawson</surname><given-names>ES</given-names></name></person-group><article-title>Scientific basis and practical aspects of creatine supplementation for athletes</article-title><source>Nutrition</source><year>2004</year><volume>20</volume><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2004.04.014</pub-id><pub-id pub-id-type="pmid">15212742</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winder</surname><given-names>WW</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes</article-title><source>Am J Physiol</source><year>1999</year><volume>277</volume><fpage>E1</fpage><lpage>E10</lpage><pub-id pub-id-type="pmid">10409121</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtaszewski</surname><given-names>JFP</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>SB</given-names></name><name><surname>Hellsten</surname><given-names>Y</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name></person-group><article-title>Glycogen dependent effects of AICAR on 5&#x02019;AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><fpage>284</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.2.284</pub-id><pub-id pub-id-type="pmid">11812734</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtaszewski</surname><given-names>JF</given-names></name><name><surname>MacDonald</surname><given-names>C</given-names></name><name><surname>Nielsen</surname><given-names>JN</given-names></name><name><surname>Hellsten</surname><given-names>Y</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Kiens</surname><given-names>B</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name></person-group><article-title>Regulation of 5&#x02019;AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle</article-title><source>Am J Physiol</source><year>2003</year><volume>284</volume><fpage>E813</fpage><lpage>E822</lpage></element-citation></ref></ref-list></back></article>